The emerging concept of lung mycobiome;Un nouveau concept

Medecine/Sciences

Volumn 31, Issue 11, 2015, Pages 945-947

  Nguyen, Linh ^a   Delhaes, Laurence ^a,b  

^a UNIV LILLE   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CHRONIC DISEASE; CYSTIC FIBROSIS; DYSBIOSIS; EXPERIMENTAL THERAPY; FUNGUS; GENETICS; HUMAN; LUNG; MICROBIOLOGY; MICROFLORA; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT DISEASES; TRENDS;

ASTHMA; CHRONIC DISEASE; CYSTIC FIBROSIS; DYSBIOSIS; FUNGI; HUMANS; LUNG; MICROBIOTA; RESPIRATORY TRACT DISEASES; THERAPIES, INVESTIGATIONAL;

EID: 84947924502     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20153111002     Document Type: Article

References (18)

1. Underhill DM, Iliev ID The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 2014; 14: 405-416.
2. Marsland BJ, Gollwitzer ES Host-microorganism interactions in lung diseases. Nat Rev Immunol 2014; 14: 827-835.
3. Charlson ES, Bittinger K, Chen J, et al. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PLoS One 2012; 7: e42786.
4. Charlson ES, Diamond JM, Bittinger K, et al. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am J Respir Crit Care Med 2012; 186: 536-545.
5. Delhaes L, Monchy S, Fréalle E, et al. The airway microbiota in cystic fibrosis: A complex fungal and bacterial community. Implications for therapeutic management. PLoS One 2012; 7: e36313.
6. Van Woerden HC, Gregory C, Brown R, et al. Differences in fungi present in induced sputum samples from asthma patients and non-Atopic controls: A community based case control study. BMC Infect Dis 2013; 13: 69.
7. Willger SD, Grim SL, Dolben EL, et al. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome 2014; 2: 40.
8. Denning DW, Pashley C, Hartl D, et al. Fungal allergy in asthma: state of the art and research needs. Clin Transl Allergy 2014; 4: 14.
9. Paugam A, Baixench MT, Demazes-Dufeu N, et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 2010; 48: (suppl 1) S32-S36.
10. Burgel PR, Baixench MT, Amsellem M, et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother 2012; 56: 869-874.
11. Rabin AS, Givertz MM, Couper GS, et al. Risk factors for invasive fungal disease in heart transplant recipients. J Heart Lung Transplant 2015; 34: 227-232.
12. Bitar D, Lortholary O, Le Strat Y, et al. Population-based analysis of invasive fungal infections, France, 2001-2010. Emerg Infect Dis 2014; 20: 1149-1155.
13. Kosmidis C, Denning DW The clinical spectrum of pulmonary aspergillosis. Thorax 2015; 70: 270-277.
14. Peleg AY, Hogan DA, Mylonakis E Medically important bacterial: fungal interactions. Nat Rev Microbiol 2010; 8: 340-349.
15. Huffnagle GB, Noverr MC The emerging world of the fungal microbiome. Trends Microbiol 2013; 21: 334-341.
16. Audebert C, Hot D, Lemoine Y, Caboche S Le séquençage haut-débit: vers un diagnostic basé sur la séquence complète de l'agent infectieux. Med Sci (Paris) 2014; 30: 1144-1151.
17. Brégeon F, Rolain JM Le résistome pulmonaire. Med Sci (Paris) 2015; 31: 947-950.
18. Andréjak C, Delhaes L Le microbiome pulmonaire en 2015. Med Sci (Paris) 2015; 31: 971-978.